Molecular Endocrinology · 2002 · 177 citations · 70 references
Life SciencesDevelopmental BiologyMolecular BiologyCarcinogenesisGene ExpressionTranscriptional RegulationCancer TranscriptomicsGrowth Factor SignalingMammary Epithelial Cell BiologyMammary Gland DevelopmentMammary TumorsDevelopmental Cell-state DynamicsGrowth FactorsInhibitory Molecule ExpressionLifetime Cancer RiskMammary Epithelial Gene RegulationMammary Gland Gene ExpressionMammary Gland MorphogenesisParity-associated Remodeling
Epidemiological studies have repeatedly demonstrated that women who undergo an early first full-term pregnancy have a significantly reduced lifetime risk of breast cancer. Similarly, rodents that have previously undergone a full-term pregnancy are highly resistant to carcinogen-induced breast cancer compared with age-matched nulliparous controls. Little progress has been made, however, toward understanding the biological basis of this phenomenon. We have used DNA microarrays to identify a panel of 38 differentially expressed genes that reproducibly distinguishes, in a blinded manner, between the nulliparous and parous states of the mammary gland in multiple strains of mice and rats. We find that parity results in the persistent down-regulation of multiple genes encoding growth factors, such as amphiregulin, pleiotrophin, and IGF-1, as well as the persistent up-regulation of the growth-inhibitory molecule, TGF-beta3, and several of its transcriptional targets. Our studies further indicate that parity results in a persistent increase in the differentiated state of the mammary gland as well as lifelong changes in the hematopoietic cell types resident within the gland. These findings define a developmental state of the mammary gland that is refractory to carcinogenesis and suggest novel hypotheses for the mechanisms by which parity may modulate breast cancer risk.
70
Expression monitoring by hybridization to high-density oligonucleotide arrays
David J. Lockhart, Helin Dong, Michael C. Byrne et al. · Nature Biotechnology · 1996 · 2.9K citations
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Susan E. Hankinson, Walter C. Willett, Graham A. Colditz et al. · The Lancet · 1998 · 1.8K citations
Structure and Function of Lipopolysaccharide Binding Protein
Ralf R. Schumann, Steven R. Leong, Gail W. Flaggs et al. · Science · 1990 · 1.7K citations
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Samy Ashkar, Georg F. Weber, Marie Sanchirico et al. · Science · 2000 · 1.1K citations
Life Sciences, Immunology, Pathology +17